Mobic (Meloxicam)

Meloxicam, the active ingredient in Mobic, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It alleviates inflammation and pain associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and juvenile rheumatoid arthritis, providing symptomatic relief in adult and pediatric patients as appropriate under medical supervision and according to prescribed dosing guidelines.

GNH USA supplies Mobic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with a focus on quality assurance and regulatory compliance.

Meloxicam is indicated for several inflammatory joint disorders, targeting the underlying inflammatory pathways to reduce pain and improve function.

Osteoarthritis: reduces joint pain and improves mobility. Rheumatoid arthritis: decreases synovial inflammation and slows disease progression. Ankylosing spondylitis: alleviates spinal stiffness and chronic back pain. Juvenile rheumatoid arthritis: provides pain relief and improves joint function in pediatric patients. Other inflammatory musculoskeletal conditions: may be used off‑label under physician guidance.

Meloxicam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal discomfort (nausea, dyspepsia). - Headache. - Dizziness. - Peripheral edema.

Serious or Rare Side Effects: - Gastrointestinal ulcer or bleeding. - Severe liver injury (hepatotoxicity). - Acute renal failure or worsening of chronic kidney disease.

Before initiating meloxicam therapy, clinicians should evaluate several safety considerations.

Assess renal function: adjust or avoid use in patients with severe renal impairment. Monitor hepatic enzymes: discontinue if signs of liver toxicity appear. Evaluate cardiovascular risk: use cautiously in patients with history of heart disease or hypertension. Avoid concurrent use with other NSAIDs or anticoagulants: increased risk of bleeding. Pregnancy and lactation: contraindicated unless benefits outweigh risks; consult specialist. Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture and light.

Meloxicam can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (warfarin, direct oral anticoagulants): increased risk of serious bleeding. - ACE inhibitors or ARBs: may reduce renal function, especially in dehydrated patients. - Lithium: meloxicam can raise lithium serum levels, risking toxicity.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance nephrotoxic potential. - SSRIs or SNRIs: combined use raises gastrointestinal bleeding risk.